HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angela E Hawley Selected Research

Angela E Hawley Research Topics

Disease

25Thrombosis (Thrombus)
01/2017 - 11/2002
18Venous Thrombosis (Deep-Vein Thrombosis)
01/2017 - 11/2002
7Inflammation (Inflammations)
09/2014 - 06/2003
5Fibrosis (Cirrhosis)
04/2015 - 11/2002
2Hemorrhage
01/2017 - 01/2017
2Venous Thromboembolism
01/2017 - 09/2002
1Sudden Infant Death (SID)
01/2017
1Stroke (Strokes)
01/2017
1Hyperlipidemias (Hyperlipidemia)
03/2012
1Pain (Aches)
06/2010
1Pathologic Constriction (Stenosis)
09/2006
1Necrosis
09/2002
1Pulmonary Embolism
09/2002

Drug/Important Bio-Agent (IBA)

19P-SelectinIBA
04/2015 - 09/2002
10Proteins (Proteins, Gene)FDA Link
03/2015 - 06/2003
6Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2017 - 11/2002
5fibrin fragment D (D-dimer)IBA
06/2013 - 12/2005
5Thromboplastin (Tissue Factor)IBA
05/2011 - 11/2002
4E-SelectinIBA
01/2017 - 09/2002
4Enoxaparin (Lovenox)FDA LinkGeneric
01/2017 - 02/2008
4EnzymesIBA
09/2006 - 11/2002
4ImmunosorbentsIBA
09/2006 - 11/2002
3SelectinsIBA
01/2017 - 11/2003
3Interleukin-6 (Interleukin 6)IBA
03/2015 - 02/2011
3LigandsIBA
03/2015 - 08/2005
3CytokinesIBA
09/2014 - 09/2002
3Interleukin-10 (Interleukin 10)IBA
09/2014 - 09/2002
3Messenger RNA (mRNA)IBA
10/2012 - 06/2003
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2012 - 06/2003
32- (4- chlorobenzyl)- 3- hydroxy- 7,8,9,10- tetrahydrobenzo(H)quinoline- 4- carboxylic acidIBA
03/2007 - 08/2005
2von Willebrand FactorIBA
04/2015 - 08/2010
2Tissue Plasminogen Activator (Alteplase)FDA Link
06/2013 - 03/2012
2Plasminogen Activators (Plasminogen Activator)IBA
03/2012 - 01/2010
2ChemokinesIBA
02/2011 - 09/2002
2Hemostatics (Antihemorrhagics)IBA
06/2010 - 03/2009
1Factor Xa InhibitorsIBA
01/2017
1uproleselanIBA
01/2017
1apixabanIBA
01/2017
1Warfarin (Coumadin)FDA LinkGeneric
01/2017
1ARC5692IBA
04/2015
1ARC15105IBA
04/2015
1Galectin 3 (LGALS3)IBA
03/2015
1Buprenorphine (Subutex)FDA LinkGeneric
09/2014
1Analgesics (Analgesic Drugs)IBA
09/2014
1Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric
09/2014
1Fibrinolytic Agents (Antithrombotic Agents)IBA
06/2013
1FibrinolysinFDA Link
06/2013
1Immunoglobulin G (IgG)IBA
10/2012
1ApolipoproteinsIBA
03/2012
1Matrix Metalloproteinases (MMPs)IBA
03/2012
1Apolipoproteins E (ApoE)IBA
03/2012
1Plasminogen Activator Inhibitor 1IBA
03/2012
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2012
1Biomarkers (Surrogate Marker)IBA
08/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2011
1Blood Proteins (Serum Proteins)IBA
06/2010
1Immunoglobulins (Immunoglobulin)IBA
03/2009
1Fibrinogen (Factor I)FDA Link
03/2009
1Membrane Proteins (Integral Membrane Proteins)IBA
03/2009
1enoxaparin sodiumFDA LinkGeneric
02/2008
1PSI-421IBA
02/2008
1AntibodiesIBA
08/2005
1InterleukinsIBA
08/2005
1CollagenIBA
08/2003
1AnticoagulantsIBA
11/2002
1Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2002

Therapy/Procedure

6Ligation
09/2014 - 11/2002
4Therapeutics
01/2017 - 08/2005
1Diet Therapy (Therapy, Diet)
01/2017
1Injections
04/2009
1Aftercare (After-Treatment)
08/2003
1Thrombolytic Therapy
11/2002